Center for Cellular Immunotherapies @ UPenn

Building on Penns leadership in Translational Medicine and investigator initiated clinical trials established over the past two decades, CCI is focused on coordinated interdisciplinary approaches for the discovery and development of core platform technologies for personalized cell and gene based therapies in cancer, autoimmune disease, infectious disease, and organ and bone marrow transplantation. CCI interacts with a coalition of investigators in nearly all departments and centers in the Perelman School of Medicine; driving clinical translation of novel and investigational immune-based therapies. CCI will fuse clinical investigators and scientists within the Abramson Cancer Center, the Institute for Immunology, the Center for...

Center for cellular immunotherapies @ upenn operates in the Research services industry.

Center for cellular immunotherapies @ upenn's revenue is 11m - 100m

Center for cellular immunotherapies @ upenn has 11 - 50 employees.